Back to results
US 9,023,799 B2Granted
Method to reduce loss of cardiac function following ischemia/reperfusion
AssigneeCellmid Limited
InventorsMitsuru Horiba, Itsuo Kodama, Takashi Muramatsu, Kenji Kadomatsu
Life of this patent
Estimating the term…
Abstract
A method to treat the chronic stage of heart injury after ischemia or reperfusion by administering Midkine to a subject in need of such treatment is described.
Claims7
A method to reduce loss in cardiac function in a subject during a chronic stage following ischemia/reperfusion, which method comprises administering to a subject that has suffered the ischemia/reperfusion an effective amount of Midkine continuously for up to two weeks following the ischemia/reperfusion, to reduce the loss in cardiac function in the chronic stage following ischemia/reperfusion.
Dependencies are inferred from the claim text.